Drug intelligence / Profile preview

juniperus scopulorum pollen extract

Development stage
Unknown
Lead developer
Greer Laboratories
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal, Sublingual, Ophthalmic, Intranasal
01

Overview

Juniperus scopulorum pollen extract is a non-standardized allergenic biologic derived from the pollen of the Rocky Mountain juniper tree. It is indicated for the skin test diagnosis of patients with a clinical history of allergy to juniper pollen and for use in allergen immunotherapy. In diagnostic applications, the extract is used to elicit a wheal-and-flare response in sensitive individuals by cross-linking allergen-specific IgE on mast cells. For therapeutic use, it is administered subcutaneously in increasing doses to induce immunological tolerance, typically characterized by a shift from a Th2-dominated allergic response to a Th1/Treg-mediated response, thereby reducing symptoms of allergic rhinitis, conjunctivitis, and asthma. The product has been available in the United States since the 1960s and is produced by several specialized manufacturers of allergenic extracts.

Other names
Rocky Mountain juniper pollen extractJuniperus scopulorum
02

Targets

A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)

Beyond the preview

Go deeper on juniperus scopulorum pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on juniperus scopulorum pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call